Skip to main content
. 2020 May 15;10(14):6201–6215. doi: 10.7150/thno.46137

Table 1.

Cohort characteristics of gastric cancer patient

Clinicopathological characteristics Number (n=69) Percent (%) CDK12 p-value
Low (n=34) High (n=35)
Age Median (range) 64 (30-86) 60.5±10.72 69±10.73 0.0149(*)
Gender Male 55 79.7 28 (82.4) 27 (77.1) 0.8535
Female 14 20.3 6 (17.6) 8 (22.9)
Pathology grade 23 33.3 8 (23.5) 15 (42.9) 0.1622
Ⅱ-Ⅲ 22 31.9 11 (32.4) 11 (31.4)
24 34.8 15 (44.1) 9 (25.7)
Clinical stage 1 4 5.9 1 (3.0) 3 (8.6) 0.7083
2 17 24.6 8 (23.5) 9 (25.7)
3 41 59.4 20 (58.8) 21 (60.0)
4 7 10.1 5 (14.7) 2 (5.7)
Pathomorphology Ulcerative type 61 88.4 30 (88.2) 31 (88.6) 0.3345
Protrude type 7 10.1 3 (8.8) 4 (11.4)
Infiltrating type 1 1.5 1 (3.0) 0 (0.0)
Tumor size(mm3) Median (range) 19.29 (3-234) 19.54±41.11 18±31.22 0.4460
Lymph node Median (range) 25 (8-71) 24.5±11.27 27±7.24 0.2346
Positive lymph node Median (range) 3 (0-42) 4±10.60 3±5.49 0.0869